SN-001
|
S578987-25mg
|
≥98% |
727699-84-5 |
25mg
|
¥ 629.9
|
期货,请咨询 |
阿拉丁 |
SN-001
|
S578987-250mg
|
≥98% |
727699-84-5 |
250mg
|
¥ 3299.9
|
期货,请咨询 |
阿拉丁 |
SN-001
|
S578987-100mg
|
≥98% |
727699-84-5 |
100mg
|
¥ 1699.9
|
期货,请咨询 |
阿拉丁 |
SN-011
|
S578984-5mg
|
≥98% |
2249435-90-1 |
5mg
|
¥ 859.9
|
现货 |
阿拉丁 |
SN-011
|
S578984-25mg
|
≥98% |
2249435-90-1 |
25mg
|
¥ 2269.9
|
现货 |
阿拉丁 |
SN-011
|
S578984-100mg
|
≥98% |
2249435-90-1 |
100mg
|
¥ 4929.9
|
现货 |
阿拉丁 |
(S)-5-苄基-2-均三甲苯基-6,6-二甲基-6,8-二氢-5H-[1,2,4]三氮唑并[3,4-c][1,4]噁嗪-2-四氟硼酸鎓盐
|
S487371-50mg
|
≥97% |
925706-40-7 |
50mg
|
¥ 840.9
|
现货 |
阿拉丁 |
四丁基 O,O-二乙基二硫代磷酸膦
|
T405121-5g
|
≥95%(T) |
96131-57-6 |
5g
|
¥ 79.9
|
现货 |
阿拉丁 |
(2′S)-2′-脱氧-2′-氟-5-乙炔基尿苷 (F-ara-EdU)
|
S479901-1mg
|
≥95% |
95740-26-4 |
1mg
|
¥ 799.9
|
现货 |
阿拉丁 |
(S)-(+)-2-(叔丁基)-3-甲基-4-咪唑烷酮三氟乙酸
|
S468223-100mg
|
≥96% |
900503-70-0 |
100mg
|
¥ 999.9
|
期货,请咨询 |
阿拉丁 |
(S)-N,N'-二甲基-1,1'-联萘二胺
|
S465665-50mg
|
≥98% |
666175-40-2 |
50mg
|
¥ 81.9
|
期货,请咨询 |
阿拉丁 |
苯乙烯-α, β-¹³C₂
|
S465456-100mg
|
≥99 atom% 13C,≥98%, containing 4-tert butyl catechol as a stabilizer |
31124-36-4 |
100mg
|
¥ 8399.9
|
期货,请咨询 |
阿拉丁 |
氨基钠
|
S434057-25g
|
≥98% |
7782-92-5 |
25g
|
¥ 241.9
|
期货,请咨询 |
阿拉丁 |
氨基钠
|
S434057-100g
|
≥98% |
7782-92-5 |
100g
|
¥ 459.9
|
期货,请咨询 |
阿拉丁 |
水杨酸钠
|
S432875-25g
|
适用于分析, 优级品 |
54-21-7 |
25g
|
¥ 259.9
|
期货,请咨询 |
阿拉丁 |
水杨酸钠
|
S432875-100g
|
适用于分析, 优级品 |
54-21-7 |
100g
|
¥ 709.9
|
期货,请咨询 |
阿拉丁 |
二水钨酸钠
|
S431260-250g
|
基础级试剂, 用于制备 |
10213-10-2 |
250g
|
¥ 999.9
|
现货 |
阿拉丁 |
二氧化硫1-甲基吡咯烷加合物
|
S405127-1g
|
≥96%(T) |
2098851-56-8 |
1g
|
¥ 76.9
|
现货 |
阿拉丁 |
Salvigenin
|
S348729-5mg
|
≥98% |
19103-54-9 |
5mg
|
¥ 1599.9
|
现货 |
阿拉丁 |
Salvigenin
|
S348729-50mg
|
≥98% |
19103-54-9 |
50mg
|
¥ 6099.9
|
现货 |
阿拉丁 |
Salvigenin
|
S348729-25mg
|
≥98% |
19103-54-9 |
25mg
|
¥ 4299.9
|
现货 |
阿拉丁 |
Salvigenin
|
S348729-1mg
|
≥98% |
19103-54-9 |
1mg
|
¥ 379.9
|
现货 |
阿拉丁 |
Salvigenin
|
S348729-100mg
|
≥98% |
19103-54-9 |
100mg
|
¥ 8199.9
|
现货 |
阿拉丁 |
金黄紫堇碱
|
S343831-5mg
|
≥98% |
6451-73-6 |
5mg
|
¥ 1999.9
|
现货 |
阿拉丁 |